RJFSA
RXDX

Raymond James Financial Services Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Raymond James Financial Services Advisors’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,036
Closed -$769K – 3343
2022
Q3 		$769K Buy
+13,036
New +$769K ﹤0.01% 1986